Neue Konzepte für druckgesteuerte Glaukomimplantate

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Autorschaft

  • R. Allemann
  • O. Stachs
  • K. Falke
  • W. Schmidt
  • S. Siewert
  • K. Sternberg
  • B. Chichkov
  • A. Wree
  • K. P. Schmitz
  • R. F. Guthoff

Organisationseinheiten

Externe Organisationen

  • Universitätsmedizin Rostock
  • Universität Rostock
Forschungs-netzwerk anzeigen

Details

Titel in Übersetzung[New concepts for pressure-controlled glaucoma implants].
OriginalspracheDeutsch
Seiten (von - bis)733-739
Seitenumfang7
FachzeitschriftDer Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft
Jahrgang110
Ausgabenummer8
PublikationsstatusVeröffentlicht - 27 Juli 2013

Abstract

In industrialized countries glaucoma is one of the most common causes that leads to blindness. It is also the most common cause of irreversible blindness worldwide. In addition to local treatment of intraocular pressure and filtering glaucoma surgery, alloplastic implants are increasingly being used in glaucoma therapy. As long-term results published in the literature of commonly used implants are unsatisfactory, it seems useful to search for new concepts. In order to avoid the well-known short-term and long-term postoperative complications a pressure-controlled microstent with antiproliferative surface modifications was developed. Additionally, the functionality of such a microstent should be investigated using an animal glaucoma model. This paper describes the concept of a microstent which drains aquous humour from the anterior chamber into the suprachoroidal space. In addition, the glaucoma models described in the literature are discussed. Unfortunately, none of the methods could be reproduced permanently. First results show a correct implantation of a coated microstent with valve where the anti-proliferative effect could be demonstrated histologically. The promising results should lead to further investigations and the final goal will be the testing of the stent in the human eye.

ASJC Scopus Sachgebiete

Zitieren

Neue Konzepte für druckgesteuerte Glaukomimplantate. / Allemann, R.; Stachs, O.; Falke, K. et al.
in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jahrgang 110, Nr. 8, 27.07.2013, S. 733-739.

Publikation: Beitrag in FachzeitschriftArtikelForschungPeer-Review

Allemann, R, Stachs, O, Falke, K, Schmidt, W, Siewert, S, Sternberg, K, Chichkov, B, Wree, A, Schmitz, KP & Guthoff, RF 2013, 'Neue Konzepte für druckgesteuerte Glaukomimplantate', Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, Jg. 110, Nr. 8, S. 733-739. https://doi.org/10.1007/s00347-013-2839-5
Allemann, R., Stachs, O., Falke, K., Schmidt, W., Siewert, S., Sternberg, K., Chichkov, B., Wree, A., Schmitz, K. P., & Guthoff, R. F. (2013). Neue Konzepte für druckgesteuerte Glaukomimplantate. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft, 110(8), 733-739. https://doi.org/10.1007/s00347-013-2839-5
Allemann R, Stachs O, Falke K, Schmidt W, Siewert S, Sternberg K et al. Neue Konzepte für druckgesteuerte Glaukomimplantate. Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2013 Jul 27;110(8):733-739. doi: 10.1007/s00347-013-2839-5
Allemann, R. ; Stachs, O. ; Falke, K. et al. / Neue Konzepte für druckgesteuerte Glaukomimplantate. in: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2013 ; Jahrgang 110, Nr. 8. S. 733-739.
Download
@article{df5cdc83ce8e44e9a2092821b1be2658,
title = "Neue Konzepte f{\"u}r druckgesteuerte Glaukomimplantate",
abstract = "In industrialized countries glaucoma is one of the most common causes that leads to blindness. It is also the most common cause of irreversible blindness worldwide. In addition to local treatment of intraocular pressure and filtering glaucoma surgery, alloplastic implants are increasingly being used in glaucoma therapy. As long-term results published in the literature of commonly used implants are unsatisfactory, it seems useful to search for new concepts. In order to avoid the well-known short-term and long-term postoperative complications a pressure-controlled microstent with antiproliferative surface modifications was developed. Additionally, the functionality of such a microstent should be investigated using an animal glaucoma model. This paper describes the concept of a microstent which drains aquous humour from the anterior chamber into the suprachoroidal space. In addition, the glaucoma models described in the literature are discussed. Unfortunately, none of the methods could be reproduced permanently. First results show a correct implantation of a coated microstent with valve where the anti-proliferative effect could be demonstrated histologically. The promising results should lead to further investigations and the final goal will be the testing of the stent in the human eye.",
author = "R. Allemann and O. Stachs and K. Falke and W. Schmidt and S. Siewert and K. Sternberg and B. Chichkov and A. Wree and Schmitz, {K. P.} and Guthoff, {R. F.}",
year = "2013",
month = jul,
day = "27",
doi = "10.1007/s00347-013-2839-5",
language = "Deutsch",
volume = "110",
pages = "733--739",
journal = "Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft",
issn = "0941-293X",
publisher = "Springer Verlag",
number = "8",

}

Download

TY - JOUR

T1 - Neue Konzepte für druckgesteuerte Glaukomimplantate

AU - Allemann, R.

AU - Stachs, O.

AU - Falke, K.

AU - Schmidt, W.

AU - Siewert, S.

AU - Sternberg, K.

AU - Chichkov, B.

AU - Wree, A.

AU - Schmitz, K. P.

AU - Guthoff, R. F.

PY - 2013/7/27

Y1 - 2013/7/27

N2 - In industrialized countries glaucoma is one of the most common causes that leads to blindness. It is also the most common cause of irreversible blindness worldwide. In addition to local treatment of intraocular pressure and filtering glaucoma surgery, alloplastic implants are increasingly being used in glaucoma therapy. As long-term results published in the literature of commonly used implants are unsatisfactory, it seems useful to search for new concepts. In order to avoid the well-known short-term and long-term postoperative complications a pressure-controlled microstent with antiproliferative surface modifications was developed. Additionally, the functionality of such a microstent should be investigated using an animal glaucoma model. This paper describes the concept of a microstent which drains aquous humour from the anterior chamber into the suprachoroidal space. In addition, the glaucoma models described in the literature are discussed. Unfortunately, none of the methods could be reproduced permanently. First results show a correct implantation of a coated microstent with valve where the anti-proliferative effect could be demonstrated histologically. The promising results should lead to further investigations and the final goal will be the testing of the stent in the human eye.

AB - In industrialized countries glaucoma is one of the most common causes that leads to blindness. It is also the most common cause of irreversible blindness worldwide. In addition to local treatment of intraocular pressure and filtering glaucoma surgery, alloplastic implants are increasingly being used in glaucoma therapy. As long-term results published in the literature of commonly used implants are unsatisfactory, it seems useful to search for new concepts. In order to avoid the well-known short-term and long-term postoperative complications a pressure-controlled microstent with antiproliferative surface modifications was developed. Additionally, the functionality of such a microstent should be investigated using an animal glaucoma model. This paper describes the concept of a microstent which drains aquous humour from the anterior chamber into the suprachoroidal space. In addition, the glaucoma models described in the literature are discussed. Unfortunately, none of the methods could be reproduced permanently. First results show a correct implantation of a coated microstent with valve where the anti-proliferative effect could be demonstrated histologically. The promising results should lead to further investigations and the final goal will be the testing of the stent in the human eye.

UR - http://www.scopus.com/inward/record.url?scp=84895836656&partnerID=8YFLogxK

U2 - 10.1007/s00347-013-2839-5

DO - 10.1007/s00347-013-2839-5

M3 - Artikel

C2 - 23887742

AN - SCOPUS:84895836656

VL - 110

SP - 733

EP - 739

JO - Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

JF - Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft

SN - 0941-293X

IS - 8

ER -